AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: The abnormal expression of BCR/ABL may lead to many diseases, including chronic granulocytes leukemia, acute lymphocyte leukemia and the related pathways, including endometrial cancer and the PI3K/Akt pathway [48–51].